SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 86 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2014. The put-call ratio across all filers is 1.76 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $64,000 | -41.8% | 245,892 | -46.1% | 0.00% | – |
| Q1 2016 | $110,000 | -61.1% | 456,570 | -43.2% | 0.00% | – |
| Q4 2015 | $283,000 | -42.8% | 804,262 | +182.8% | 0.00% | -100.0% |
| Q3 2015 | $495,000 | -47.4% | 284,393 | -32.6% | 0.00% | 0.0% |
| Q2 2015 | $941,000 | +155.0% | 421,992 | +121.9% | 0.00% | 0.0% |
| Q1 2015 | $369,000 | -61.0% | 190,186 | -46.8% | 0.00% | 0.0% |
| Q4 2014 | $947,000 | -54.3% | 357,491 | -48.0% | 0.00% | -66.7% |
| Q3 2014 | $2,070,000 | -47.6% | 687,566 | -28.8% | 0.00% | -40.0% |
| Q2 2014 | $3,951,000 | +213.3% | 966,000 | +301.3% | 0.01% | +150.0% |
| Q4 2013 | $1,261,000 | -29.9% | 240,721 | -15.6% | 0.00% | -33.3% |
| Q3 2013 | $1,799,000 | +509.8% | 285,124 | +381.8% | 0.00% | +200.0% |
| Q2 2013 | $295,000 | – | 59,180 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 28,639,349 | $123,436,000 | 94.21% |
| Verity Asset Management, Inc. | 103,021 | $456,000 | 0.47% |
| NBW CAPITAL LLC | 242,153 | $1,044,000 | 0.27% |
| Old West Investment Management, LLC | 69,997 | $301,000 | 0.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 196,639 | $848,000 | 0.12% |
| SOPHROSYNE CAPITAL LLC | 25,700 | $111,000 | 0.10% |
| Cutler Capital Management, LLC | 45,000 | $194,000 | 0.08% |
| Rotella Capital Management, Inc. | 11,700 | $50,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 66,397 | $286,000 | 0.06% |
| Roundview Capital LLC | 21,100 | $91,000 | 0.04% |